Patient
SITE005-0246
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE005 (FRA) (Dr. Muller)
consented 2026-06-12
Adverse events
1
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 1
mild
assessed
2026-09-15
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-03-11 (study day 77); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.